glp 1 agonists and inflammation Frontiers Can one drug do it
Description
References Min T, Bain SC
Potential sleep disturbances and bone pain in some individuals
Patients with a history of pancreatitis face substantially higher recurrence risk and should discuss alternative treatments with their healthcare provider, as FDA labeling advises considering other therapies in this population
Wang Y, Perfetti R, Greig NH, Holloway HW, DeOre KA, Montrose-Rafizadeh C, et al
GLP-1 receptor agonists for the treatment of obesity: Role as a promising approach
10.1016/j.diabres.2014.04.006 24
